Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | NFATC3 |
| Upstream (Parents) |
|---|
| (<<) NSFL1C → NFATC3 |
| (<<) ATP6V0D1 → NFATC3 |
| (<<) WBP11 → NFATC3 |
| (<<) VAMP5 → NFATC3 |
| Downstream (Children) |
|---|
| NFATC3 → SLC10A3 (>>) |
| NFATC3 → CALHM2 (>>) |
| NFATC3 → NCR2 (>>) |
| NFATC3 → GYG2 (>>) |
| NFATC3 → MYO1D (>>) |
| NFATC3 → ZNF81 (>>) |
| NFATC3 → KATNB1 (>>) |
| NFATC3 → TMPRSS4 (>>) |
| NFATC3 → TSPAN4 (>>) |
| NFATC3 → VAMP5 (>>) |
| NFATC3 → HOXD11 (>>) |
| NFATC3 → PPFIA2 (>>) |
| NFATC3 → ATP6V0A2 (>>) |
| NFATC3 → ITPKB (>>) |
| NFATC3 → CYP4F2 (>>) |
| NFATC3 → FAM65A (>>) |
| NFATC3 → MASP2 (>>) |
| NFATC3 → CX3CL1 (>>) |
| NFATC3 → IMPA2 (>>) |
| NFATC3 → DDX19A///DDX19B (>>) |
| NFATC3 → GRIK4 (>>) |
| NFATC3 → DUX1 (>>) |
| NFATC3 → ADA (>>) |
